oxazoles has been researched along with substance p in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Costa, E; Guidotti, A; Naik, SR | 1 |
Ek, L; Theodorsson, E | 1 |
Placheta, P; Singer, E | 1 |
Bourgoin, S; Cesselin, F; Collin, E; Frechilla, D; Hamon, M; Mauborgne, A; Pohl, M | 1 |
Advenier, C; Biyah, K | 1 |
Chen, IJ; Lo, WJ; Lo, YC; Wu, BN; Yeh, JL | 1 |
Hitzel, L; Keown, LE; Ladduwahetty, T; Lewis, RT; MacLeod, AM; Merchant, KJ; Stevenson, GI; Verrier, H | 1 |
Ball, RG; Bao, J; Bunda, J; Chicchi, G; Cook, J; DeVita, RJ; Doss, GA; Eng, W; Gantert, L; Hargreaves, R; Hora, DF; Jiang, J; Karanam, B; Kassick, AJ; Kumar, S; Lin, P; Lu, H; Madeira, M; Mills, SG; Purcell, M; Samuel, K; Tong, X; Tsao, KL; Tschirret-Guth, R; Wang, H; Wilson, D | 1 |
8 other study(ies) available for oxazoles and substance p
Article | Year |
---|---|
Central GABA receptor agonists: comparison of muscimol and baclofen.
Topics: Aminobutyrates; Animals; Anticonvulsants; Baclofen; Cerebellum; Cyclic GMP; Diazepam; gamma-Aminobutyric Acid; Harmaline; Isoniazid; Male; Motor Activity; Muscle Tonus; Mycotoxins; Oxazoles; Phenobarbital; Quaternary Ammonium Compounds; Rats; Receptors, Drug; Strychnine; Substance P | 1976 |
Tachykinins and calcitonin gene-related peptide in oxazolone-induced allergic contact dermatitis in mice.
Topics: Animals; Calcitonin Gene-Related Peptide; Dermatitis, Contact; Ear; Male; Mice; Mice, Inbred C57BL; Neurokinin A; Oxazoles; Oxazolone; Substance P; Tachykinins | 1990 |
Reduction of [3H]muscimol binding sites in rat dorsal spinal cord after neonatal capsaicin treatment.
Topics: Animals; Animals, Newborn; Capsaicin; Fatty Acids, Unsaturated; Ganglia, Spinal; Muscimol; Neurons; Oxazoles; Rats; Receptors, Cell Surface; Receptors, GABA-A; Sodium; Strychnine; Substance P | 1980 |
Differential effects of the novel analgesic, S 12813-4, on the spinal release of substance P- and calcitonin gene-related peptide-like materials in the rat.
Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Calcitonin Gene-Related Peptide; Dioxanes; Idazoxan; In Vitro Techniques; Injections, Spinal; Male; Norepinephrine; Oxazoles; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P | 1994 |
Effects of three alpha 2-adrenoceptor agonists, rilmenidine, UK 14304 and clonidine on bradykinin- and substance P-induced airway microvascular leakage in guinea-pigs.
Topics: Acetylcholine; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Bradykinin; Brimonidine Tartrate; Capillaries; Capillary Permeability; Clonidine; Dioxanes; Extravascular Lung Water; Guinea Pigs; Idazoxan; Oxazoles; Prazosin; Quinoxalines; Rilmenidine; Substance P; Trachea | 1995 |
Capsazocaine: a capsaicin-sensitive functional antagonist displays an argument on sensory capsaicin receptor.
Topics: Animals; Benzoates; Blood Pressure; Bronchi; Calcitonin Gene-Related Peptide; Female; Guinea Pigs; Heart Rate; Ileum; In Vitro Techniques; Injections, Spinal; Male; Myocardial Contraction; Oxazoles; Rats; Rats, Wistar; Receptors, Drug; Reflex; Sensory Receptor Cells; Spinal Cord; Substance P; Trachea; Vagus Nerve | 1997 |
An efficient protocol for the preparation of primary alcohols bearing a beta-chiral center via an oxazolidinone auxiliary mediated resolution, and application to the synthesis of 4,4-disubstituted piperidine substance P antagonists.
Topics: Alcohols; Calorimetry; Diazonium Compounds; Magnetic Resonance Spectroscopy; Oxazoles; Piperidines; Stereoisomerism; Substance P | 2000 |
2-[(3aR,4R,5S,7aS)-5-{(1S)-1-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxyethoxy}-4-(2-methylphenyl)octahydro-2H-isoindol-2-yl]-1,3-oxazol-4(5H)-one: a potent human NK1 receptor antagonist with multiple clearance pathways.
Topics: Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Glucuronides; Humans; Isoindoles; Metabolic Clearance Rate; Neurokinin-1 Receptor Antagonists; Oxazoles; Peptide Fragments; Substance P | 2013 |